Search

everythinglearnresearchcommunity

for

Search:↓

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

The combination therapy effectively treats infertility in PCOS without major side effects.

Including androgens in hormone therapy may lower breast cancer risk.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Some gonadal hormone drugs can block filovirus entry into cells.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

Cancer prevention has advanced significantly, with some strategies proving successful.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Monilethrix is a genetic hair disorder affecting hair shape, seen in two brothers.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.